
- Accepting New Patients
- Telehealth Visits
- Insurances Accepted

Amy Ransohoff, MD
She | Her | HersObstetrics and Gynecology- Accepting New Patients
- Telehealth Visits
- Insurances Accepted



Amy Ransohoff, MD
She | Her | HersObstetrics and Gynecology- Accepting New Patients
- Telehealth Visits
- Insurances Accepted
On this page
About me
Dr. Amy Ransohoff is an obstetrician and gynecologist. She provides a full range of obstetric and gynecologic care in both the clinic and the hospital, including prenatal care, labor and delivery, reproductive and contraceptive care, minimally invasive gynecologic surgery and in-office procedures such as endometrial biopsy and hysteroscopy. She also treats conditions including abnormal uterine bleeding, fibroids, ovarian cysts, perimenopause and menopause symptoms and vulvar conditions. She has additional expertise in the diagnosis and management of dysplasia (pre-cancer) of the cervix, vagina and vulva and performs LEEP procedures, cold knife cone biopsies, cervical cryotherapy and laser ablation to treat this condition.
Ransohoff is passionate about medical education, quality-improvement efforts and providing personalized care that is based on professional experience and the best research to all patients.
Ransohoff earned her medical degree at UCSF, where she also completed a residency in obstetrics, gynecology and reproductive sciences.
Education
School
- MD, UCSF School of Medicine
Academic Title
- Health Sciences Clinical Professor
Care Keywords
Services
- Obstetrics and Gynecology
Locations
Provider Research Listing
Browse clinical trials and publications by this provider
Publications
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.